Unlike the defective apoptotic machinery reported in some AML [41] and colorectal cancer subsets [42], all tested GC lines were effectively killed by the triple combination of BCL2, BCLXL, and MCL1 inhibitors. Here, BCL2L1 is linked to acute myeloid leukemia.